1Lepre F,Rigby R,Hawley C,et al.A double-blind placebo controlled trial of simavastatin for the treatment of dyslipidaemia in renal allografe recipients[].Clinical Transplantation.1999
2Barbagallo CM,Pinto A,Gallo S,et al.Carotid atherosclerosis in renal transplant recipients: relationships with cardiovascular risk factors and plasma lipoproteins[].Transplantation.1999
3Schena A,Di PS,Morrone LF,et al.Are lipid-dependent indications of cardiocascular risk affected by renal transplantation[].Clinical Transplantation.2000
4Lopes IM,Martin M,Errasti P,et al.Benefits of a dietary intervention on weight loss, body composition and lipid profile after renal transplantation[].Nutrition.1999
5Castro R,Queiros J,Fonseca I,et al.Therapy of post-renal transplantation hyperlipidaemia: comparative study with simvastation and fish oil[].Nephrology Dialysis Transplantation.1997
6Wanner C,Quaschning T,Weingarnter K.Impact of dyslipidaemia in renal transplant recipients[].Current Opinion in Urology.2000
7Quaschning T,Mainka T,Nauck M,et al.Immunosuppression enhances atherogenicity of lipid profile after transplantation[].Kidney International.1999
8Banyai FS,Gottsauner WM,Stepan E,et al.Lipoprotein pattern in end-stage renal disease and following successful renal transplantation[].Clinical Transplantation.1997
9John GT,Dakshinamurthy DS,Jeyaseelan L,et al.The effect of cyclosporin A on plasma lipid during the first year after renal transplantation[].The National Medical Journal of India.1999
10Cuecas A,Maiz A,Arteaga A,et al.Dyslipidemias in renal diseases: pathogenesis and treatment[].Revista Medica de Chile.1998
